Top 10 Seed Investors in Biotechnology, Pharma & Life Sciences
| Rank | Investor Name |
|---|---|
| 1 | SOSV |
| 2 | IndieBio |
| 3 | Draper Associates |
| 4 | ZAKA VC |
| 5 | Alumni Ventures |
| 6 | Pioneer Fund |
| 7 | Luxe Capital Partners LLC |
| 8 | Khosla Ventures |
| 9 | Plug and Play Tech Center |
| 10 | PsyMed Ventures |
Seed activity in this category runs heavily through the accelerator ecosystem and the funds that follow its cohorts. Platform science and pharma partnership appetite drive the category, with specialist funds leading most rounds. For a company raising at this stage, these are the highest-velocity check writers in the category, and the accelerator and syndicate paths are often the most direct way to reach them.
The CapitalDart directory identifies the right person to contact at each of these firms, with their individual investment criteria.
Create a free account and get the contacts for the investors above.
Rankings cover January 2025 to July 2026 investment activity in US and Canada companies. Seed and early-stage rankings measure deal participation, not suitability for every raise.